medline.ch Onkologie Gynäkologische Tumoren

	MAPK signaling reprogramming via integrative TCM-Western medicine strategy: mechanistic interactions between bioactive herbal components and chemotherapy in ovarian cancer therapy - a comprehensive review. J Ovarian Res Wang S, Liu F, Han F. PMID: 41372788 [PubMed - as supplied by publisher]
	Development and optimisation of Polyelectrolyte Complex Nanoparticles Loaded with Sorafenib by Central Composite Design (CCD): In Vitro and In Vivo Studies for the Treatment of Triple Negative Breast Cancer. Pharm Res Kale SA, Deokar SS, Shaikh KS. PMID: 41372691 [PubMed - as supplied by publisher]
	Development and validation of a nomogram incorporating YpT stage for predicting ypN0 using multicenter data in clinically node-positive breast cancer. Sci Rep Shigematsu H, Sasada S, Hashizume J, Sasada T, Ozaki S, Noma M, Yoshiyama T, Noriko G, Kawamata A, Emi A, Kaneko Y, Kajitani K, Itagaki T, Okada M. PMID: 41372507 [PubMed - as supplied by publisher]
	Ultra-processed food consumption and the risk of breast cancer incidence and death: a prospective cohort study. Sci Rep Chen B, Liu H, Wang R, Lu J. PMID: 41372318 [PubMed - as supplied by publisher]
	Different association of gBRCA1 and gBRCA2 variants with HER2-low status in invasive breast cancer: findings from a Ukrainian study. Sci Rep Livshun S, Kozakov D, Kruhlykov, Koshyk O, Kobyliak N, Seleznov O, Matvieieva A, Shparyk Y, Volodko N, Zavizion V, Khmel A, Kharchenko K, Otchenash N, Andriiv A, Sulaieva O. PMID: 41372292 [PubMed - as supplied by publisher]
	Circulating tumor cells in breast cancer bone metastasis: mechanisms, clinical relevance, and future directions. Cell Death Discov Ma L, Wang Y, Qiu S, Shi M, Tang W, Hu H, Li C, Lu H, Wang X. PMID: 41372129 [PubMed - as supplied by publisher]
	Integrating Robotic Bilateral Axillo-Breast Approach Thyroidectomy with Molecular Diagnostics and Artificial Intelligence in Thyroid Cancer Care. Biomol Ther (Seoul) Deng Q, Men X, Jin D, Bai Y. PMID: 41371995 [PubMed - as supplied by publisher]
	Three-Month Functional Exercise Reduces Upper Limb Lymphedema After Breast Cancer Surgery: A Prospective Randomized Controlled Trial. Tohoku J Exp Med Hu M, Yang L, Han J, Zhu W, Yang S, Wang X, Chen X. PMID: 41371689 [PubMed - as supplied by publisher]
	Pseudogenes in Breast Cancer Pathogenesis and Their Clinical Utility. Crit Rev Oncol Hematol Kannampuzha I, Ghasemi F, Parsyan A. PMID: 41371458 [PubMed - as supplied by publisher]
	Development of a lactylation-related molecular classification and machine learning-based gene signature to predict survival, response to immunotherapy for ovarian cancer. Pathol Res Pract Luan N, Jin F, Hu Z, Lu M, Gao J, Zhu L. PMID: 41371064 [PubMed - as supplied by publisher]
	Liposomal irinotecan in patients with HER2-negative breast cancer and brain metastases: The PHENOMENAL phase 2 study. Eur J Cancer Borrego MR, López-Bravo DP, Vila MM, Pérez-García JM, Fernández M, Tormo SB, García-Saenz JÁ, Lema L, Garau I, Cortez P, Torres AA, Conejo EA, Calvo I, Ferrer N, Blancas I, Amillano K, Santasusagna S, Benderra MA, Alcalá-López D, Antonarelli G, Sampayo-Cordero M, Llombart-Cussac A, Cortés J. PMID: 41371050 [PubMed - as supplied by publisher]
	Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer. N Engl J Med Loibl S, Park YH, Shao Z, Huang CS, Barrios C, Abraham J, Prat A, Niikura N, Im SA, Li W, Li H, Wang Y, Yao H, Kim SB, Geng CZ, Rodriguez Pantigoso W, Ramírez Godinez FJ, Song C, Ching Chang Y, Antoniazzi A, Chen SC, Li Z, Nowecki Z, Lim J, Mathias E, Sato Y, Lu W, Abdel-Monem H, Untch M, Geyer CE Jr, DESTINY-Breast05 Trial Investigators. PMID: 41370739 [PubMed - as supplied by publisher]
	Side effects of hormone therapy in patients with malignant breast neoplasm: a cross-sectional study. Rev Bras Enferm de Freitas Corpes E, Yanez RJV, Saraiva Dos Santos CPR, Barbosa MD, da Cruz Alencar MMS, de Almeida PC, Fernandes AFC, Barbosa Castro RCM. PMID: 41370618 [PubMed - indexed for MEDLINE]
	A review on herbal interventions and nanotechnological advancements for managing polycystic ovarian syndrome. JBRA Assist Reprod Sharma K, Bhardwaj S, Nagarajan K. PMID: 41370421 [PubMed - indexed for MEDLINE]
	Prevalence and determinants of precancerous cervical lesions among women screened for cervical cancer in Africa: A systematic review and meta-analysis. PLoS One Mengistie BA, Aragaw GM, Anteneh TA, Wondie KY, Kassie AT, Abuhay AE, Biset WM, Mulatu GG, Tsega NT. PMID: 41370265 [PubMed - indexed for MEDLINE]
	Differences in Clinical Trial Availability vs Distribution of Disease Among Gynecological Cancers. Oncology (Williston Park) Andrea I Nañez Md, Velez MA, Mae Zakhour Md, Garon EB. PMID: 41370239 [PubMed - indexed for MEDLINE]
	Cognitive function during endocrine treatment with or without cyclin-dependent kinase 4/6 inhibitors for advanced breast cancer. Cancer Luijendijk MJ, Lee Meeuw Kjoe PR, Wortelboer N, van Ommen-Nijhof A, van Leeuwen-Stok AE, Agelink van Rentergem JA, Vermeulen IE, Konings IR, Jager A, Sonke GS, van der Wall E, Schagen SB. PMID: 41370190 [PubMed - indexed for MEDLINE]
	Breast Cancer Progression by the FGF/FGFR Axis: A Metabolic Perspective. J Mammary Gland Biol Neoplasia Tuokkola JE, Schwertfeger KL. PMID: 41369841 [PubMed - as supplied by publisher]
	HER2CLIMB-05: A Phase 3 Study of Tucatinib Versus Placebo in Combination with Trastuzumab and Pertuzumab as First-line Maintenance Therapy for HER2+ Metastatic Breast Cancer. J Clin Oncol Dieras V, Curigliano G, Martin M, Lerebours F, Tsurutani J, Savard MF, Jerzak KJ, Hu X, Martins de Aquino Pimentel LC, O'Sullivan CC, Tokunaga E, Okines A, Huang CS, Jacot W, Sohn J, Cronemberger Silva E, Mueller V, Yang S, Granata G, Shen Q, Santarpia L, Hamilton E. PMID: 41369677 [PubMed - as supplied by publisher]
	Antiandrogens and insulin sensitizers in PCOS management. Minerva Obstet Gynecol Lello S, Fagotti A, Colonna L, DI Lella G, Vignali M, Capozzi A. PMID: 41369212 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 321622

Seite 1 von 16082

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung